Inhibition of angiogenesis by blockers of volume-regulated anion channels.

[1]  J. Michel,et al.  Angiogenic Growth Factors , 1999 .

[2]  R. Nicosia,et al.  Autoregulation of angiogenesis by cells of the vessel wall. , 1999, International review of cytology.

[3]  T. Kooistra,et al.  Effect of steroid hormones and retinoids on the formation of capillary-like tubular structures of human microvascular endothelial cells in fibrin matrices is related to urokinase expression , 1998 .

[4]  H. Augustin,et al.  Antiangiogenic tumour therapy: will it work? , 1998, Trends in pharmacological sciences.

[5]  G. Stancel,et al.  Triphenylethylene antiestrogens induce uterine vascular endothelial growth factor expression via their partial estrogen agonist activity. , 1997, Cancer letters.

[6]  B. Nilius,et al.  Swelling-activated efflux of taurine and other organic osmolytes in endothelial cells. , 1997, The American journal of physiology.

[7]  P. Lelkes,et al.  The thrombin receptor in adrenal medullary microvascular endothelial cells is negatively coupled to adenylyl cyclase through a Gi protein. , 1997, Biochimica et biophysica acta.

[8]  D. Lindner,et al.  Effects of tamoxifen and interferon‐β or the combination on tumor‐induced angiogenesis , 1997, International journal of cancer.

[9]  B. Nilius,et al.  Inhibition by mibefradil, a novel calcium channel antagonist, of Ca2+‐ and volume‐activated Cl− channels in macrovascular endothelial cells , 1997, British journal of pharmacology.

[10]  B. Nilius,et al.  Multiple types of chloride channels in bovine pulmonary artery endothelial cells. , 1997, Journal of vascular research.

[11]  J. Russo,et al.  Tamoxifen down-regulates CD36 messenger RNA levels in normal and neoplastic human breast tissues. , 1997, Cancer research.

[12]  E. De Clercq,et al.  The sulfonic acid polymers PAMPS [poly(2-acrylamido-2-methyl-1-propanesulfonic acid)] and related analogues are highly potent inhibitors of angiogenesis. , 1997, Oncology research.

[13]  S. Baatout.  Endothelial differentiation using Matrigel (review). , 1997, Anticancer research.

[14]  B. Nilius,et al.  Properties of volume-regulated anion channels in mammalian cells. , 1997, Progress in biophysics and molecular biology.

[15]  E. Abel.  Clinical applications of research on angiogenesis , 1996 .

[16]  B. Hennig,et al.  Antiestrogens inhibit endothelial cell growth stimulated by angiogenic growth factors. , 1996, Anticancer research.

[17]  V. V. van Hinsbergh,et al.  Cooperative effect of TNFalpha, bFGF, and VEGF on the formation of tubular structures of human microvascular endothelial cells in a fibrin matrix. Role of urokinase activity , 1996, The Journal of cell biology.

[18]  B. Nilius,et al.  Characterization of Volume-activated Chloride Currents in Endothelial Cells from Bovine Pulmonary Artery , 1996, The Journal of Membrane Biology.

[19]  E. Kohn,et al.  Angiogenesis: role of calcium-mediated signal transduction. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[20]  T. Voets.  Blockers of valium activated Cl^- currents inhibit endothelial proliferation , 1995 .

[21]  H. Degani,et al.  Tamoxifen enhances cell death in implanted MCF7 breast cancer by inhibiting endothelium growth. , 1994, Cancer research.

[22]  S Amerini,et al.  Nitric oxide mediates angiogenesis in vivo and endothelial cell growth and migration in vitro promoted by substance P. , 1994, The Journal of clinical investigation.

[23]  S. Mishra,et al.  Selective inhibition of T-type Ca2+ channels by Ro 40-5967. , 1994, Circulation research.

[24]  B. Nilius,et al.  Activation of a Cl- current by hypotonic volume increase in human endothelial cells , 1994, The Journal of general physiology.

[25]  P. Peristeris,et al.  Evidence that nitric oxide is an endogenous antiangiogenic mediator , 1994, British journal of pharmacology.

[26]  J. Folkman,et al.  Quantitation of angiogenesis and antiangiogenesis in the chick embryo chorioallantoic membrane. , 1994, Microvascular research.

[27]  E. Cragoe,et al.  Amiloride inhibition of angiogenesis in vitro. , 1993, The Journal of experimental zoology.

[28]  P. Weissberg,et al.  Tamoxifen decreases the rate of proliferation of rat vascular smooth-muscle cells in culture by inducing production of transforming growth factor beta. , 1993, The Biochemical journal.

[29]  D. Collins,et al.  Inhibition of angiogenesis by antiestrogens. , 1993, Cancer research.

[30]  H. Dvorak,et al.  Vascular Permeability Factor, Fibrin, and the Pathogenesis of Tumor Stroma Formation a , 1992, Annals of the New York Academy of Sciences.

[31]  Y. Ikada,et al.  Effects of Nicardipine on Tube Formation of Bovine Vascular Endothelial Cells In Vitro , 1992, Stroke.

[32]  R. Greger,et al.  Chemical probes for anion transporters of mammalian cell membranes. , 1992, The American journal of physiology.

[33]  D. Ingber,et al.  Inhibition of angiogenesis. , 1992, Seminars in cancer biology.

[34]  R. Nicosia,et al.  Growth of microvessels in serum-free matrix culture of rat aorta. A quantitative assay of angiogenesis in vitro. , 1990, Laboratory investigation; a journal of technical methods and pathology.

[35]  H. Kleinman,et al.  Role of laminin and basement membrane in the morphological differentiation of human endothelial cells into capillary-like structures , 1988, The Journal of cell biology.

[36]  R. Thompson,et al.  Mechanisms of angiogenesis. , 1987, Annual review of physiology.

[37]  S. Schwartz,et al.  Neovascular responses induced by cultured aortic endothelial cells , 1983, Journal of cellular physiology.